Breast Cancer
Showing NaN - NaN of 420
Colitis, Diarrhea, Malignant Genitourinary System Tumor Trial in Houston (Fecal Microbiota Transplantation, Loperamide)
Recruiting
- Colitis
- +8 more
- Fecal Microbiota Transplantation
- Loperamide
-
Houston, TexasM D Anderson Cancer Center
Oct 17, 2022
Breast Cancer Trial in United States (Selene)
Recruiting
- Breast Cancer
- Selene
-
Tampa, Florida
- +7 more
Oct 12, 2022
Breast Cancer Trial in Houston, San Juan (Baseline Fitness Test, Questionnaires, Individualized Exercise Program)
Active, not recruiting
- Breast Cancer
- Baseline Fitness Test
- +3 more
-
Houston, Texas
- +1 more
Oct 11, 2022
Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)
Completed
- Breast Cancer
- Panitumumab
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Sep 20, 2022
Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)
Completed
- Breast Cancer
- NeuVax vaccine
- +2 more
-
Santa Monica, California
- +23 more
Sep 15, 2022
Breast Cancer Trial in Houston (Yoga Group, Stretching Control Group, Waitlist Control Group)
Completed
- Breast Cancer
- Yoga Group
- +3 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 30, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Breast Cancer Trial in Houston (Tibetan Meditation Program, No Meditation)
Completed
- Breast Cancer
- Tibetan Meditation Program
- No Meditation
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 26, 2022
Breast Cancer Trial in Houston (Mindfulness-Based Relationship Enhancement (MBRE), Self-Help Materials, Pain Assessment)
Completed
- Breast Cancer
- Mindfulness-Based Relationship Enhancement (MBRE)
- +6 more
-
Houston, Texas
- +1 more
Aug 22, 2022
Ovarian Cancer, Breast Cancer Trial in Worldwide (Olaparib)
Enrolling by invitation
- Ovarian Cancer
- Breast Cancer
-
Boca Raton, Florida
- +98 more
Aug 22, 2022
Breast Cancer Trial in United States (Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test)
Recruiting
- Breast Cancer
- Breast Cancer Index (BCI) Risk of Recurrence & Extended Endocrine Benefit Test
-
Daphne, Alabama
- +104 more
Aug 17, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Breast Cancer Trial in Houston (Navigator Phone Calls, Exit Interview)
Not yet recruiting
- Breast Cancer
- Navigator Phone Calls
- Exit Interview
-
Houston, TexasMD Anderson Cancer Center
Aug 16, 2022
Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)
Recruiting
- Breast Cancer
- Solid Tumor, Adult
-
Atlanta, Georgia
- +3 more
Aug 12, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Breast Cancer Trial in Houston (Durvalumab, Trastuzumab, Pertuzumab)
Recruiting
- Breast Cancer
- Durvalumab
- +2 more
-
Houston, TexasHouston Methodist Cancer Center
Aug 5, 2022